SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-11-122172
Filing Date
2011-05-02
Accepted
2011-05-02 17:22:31
Documents
5
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 457118
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9718
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9922
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3765
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3944
  Complete submission text file 0001193125-11-122172.txt   485500
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19825 | Film No.: 11801940
SIC: 2834 Pharmaceutical Preparations